Elan Puts Itself Up For Sale To Avert Royalty's $8B Hostile Bid

Law360, New York (June 14, 2013, 4:20 PM EDT) -- On the heels of Johnson & Johnson divesting its stakes in Elan Corp. PLC, the Irish company on Friday put itself up for sale as it looks to fend off an $8 billion hostile bid from Royalty Pharma Inc. and strike a better deal.

The move is just the latest in a six-month saga regarding Royalty's play for the Irish biotechnology company, and it comes just a day after a Dublin court gave Royalty some hope that it won't have to withdraw its bid if Elan...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.